25 26 27 49 lactams, which remain first line antibiotics for many infections, and finding new ways to 50 maintain their clinical effectiveness is a priority. Here we report that impaired alanine 51 transport in an MRSA cycA mutant was associated with hyper-susceptibility to β-lactam 52 antibiotics and D-cycloserine (DCS). DCS, which is used in the treatment of multi-drug 53 resistant tuberculosis infections, re-sensitised MRSA to oxacillin and other β-lactams in vitro 54 and significantly enhanced oxacillin activity in a mouse model of bacteraemia. DCS also 55 sensitised other ESKAPE pathogens to β-lactams. These findings reveal important roles for 56 alanine transport and the pathway for D-alanine incorporation into peptidoglycan in 57 controlling the susceptibility of MRSA to β-lactam antibiotics. 58 59 Whilst many bacteria can exhibit resistance to select antimicrobials, isolates of the human 60 pathogen Staphylococcus aureus can express resistance to all licensed anti-staphylococcal 61 drugs. This results in significant morbidity and mortality, with up to 20% of patients with 62 systemic methicillin resistant S. aureus (MRSA) infections dying, despite receiving treatment 63 with anti-staphylococcal drugs (1). Although aggressive hospital infection prevention and 64 control initiatives appear to be having a positive impact on hospital-acquired MRSA rates in 65 developed countries, S. aureus infections caused by community-associated MRSA strains 66
Abstract. Prolonging the clinical effectiveness of β-lactams, which remain first-line 28 antibiotics for many infections, is an important part of efforts to address antimicrobial 29 resistance. We report here that inactivation of the predicted D-cycloserine (DCS) transporter 30 gene cycA re-sensitizes MRSA to β-lactam antibiotics. The cycA mutation also resulted in 31 hyper-susceptibility to DCS, an alanine analogue antibiotic that inhibits the alanine 32 racemase and D-alanine ligase enzymes required for D-alanine incorporation into 33 peptidoglycan. Amino acid transport studies showed that CycA functions as an alanine 34 permease, and that impaired alanine transport in the cycA mutant correlated with increased 35 susceptibility to oxacillin and DCS. The cycA mutation was accompanied by increased 36 accumulation of muropeptides with tripeptide stems lacking the terminal D-ala-D-ala, and 37 reduced peptidoglycan cross linking. Exposure of MRSA to DCS was also associated with a 38 dose-dependent accumulation of muropeptides with tripeptide stems and reduced PG 39 crosslinking. Because impaired alanine transport or DCS-treatment have similar effects on 40 PG structure, synergism between β-lactams and DCS was investigated. DCS re-sensitised 41 MRSA to β-lactam antibiotics in vitro and significantly enhanced MRSA eradication by 42 oxacillin in a mouse bacteraemia model. The susceptibility of several other ESKAPE group 43 pathogens to β-lactams was also increased by DCS. These data reveal that impaired uptake 44 of alanine or DCS-meditated inhibition of D-alanine incorporation into peptidoglycan 45 increases the susceptibility of MRSA to β-lactam antibiotics. 46 47 Importance. Treatment options for infections caused by ESKAPE group pathogens continue 48 to dwindle with increasing antimicrobial resistance. Particularly important are the β-
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Mutation of cycA increases the susceptibility of MRSA to β-lactam antibiotics. To identify 102 new ways of controlling expression of methicillin resistance, we sought to identify novel 103 mutations involved in this phenotype. To achieve this, an unbiased screen of the Nebraska 104 Transposon Mutant Library (NTML) was performed using a disk diffusion assay to identify 105 mutants with increased susceptibility to cefoxitin. The parent strain of the library (JE2, a 106 derivative of USA300 LAC cured of plasmids p01 and p03 (15)) was used as a positive 107 control. Phage 80α-mediated backcross of transposon mutations into the parent strain JE2, 108 together with genetic complementation were used to confirm the role of putative genes 109 involved in cefoxitin resistance. Only mutants verified by both transduction and 110 complementation were examined further. Among the mutants identified was NE810 111 (SAUSA300_1642) ( Fig. 1A) , which exhibited significantly increased susceptibility to cefoxitin 112 as determined by a disk diffusion assay ( Fig. S1A ) and a >500-fold increase in susceptibility 113 to oxacillin as determined by E-test ( Fig. 1B) . Consistent with this, NE810 was previously 114 reported to be one of several NTML mutants shown to be more susceptible to amoxicillin 115 (16), but was not investigated further. RT-qPCR analysis revealed that expression of mecA 116 was not significantly affected in NE810 compared to JE2 (Fig. S1B ), whilst whole genome 117 sequence analysis of NE810 further revealed that the SCCmec element was fully intact and 118 that no other mutations were present (data not shown). These findings implied that 119 increased cefoxitin susceptibility was not attributable to a failure of this strain to express a 120 functional mecA gene product or disruption/mutation of an auxiliary gene essential for 121 expression of resistance. Transduction of the cycA transposon insertion into several MRSA 122 strains from a number of clonal complexes and with different SCCmec types (USA300 strains 123 JE2, FPR3757 and LAC-13C, DAR173, DAR22 and DAR169 (17)) was also accompanied by 124 significant increases in cefoxitin and oxacillin susceptibility (Table 1) . 125 126 Mutation of cycA increases susceptibility to D-cycloserine. SAUSA300_1642 is annotated as 127 a D-serine/L-and D-alanine/glycine transporter with homology to CycA in Mycobacterium susceptible to DCS than the wild type JE2 and was successfully complemented by the wild- 133 type cycA gene ( Fig. 2A) . By broth dilution, the DCS MIC decreased from 32 g/ml in JE2 to 2 134 g/ml in NE810 (Table 1) . The cycA mutants of the MRSA strains USA300, DAR173, DAR22 135 and DAR169 exhibited similar and significant increases in susceptibility to DCS (Table 1) . 136 Transduction of the cycA allele from NE810 into the MSSA strains 8325-4 and ATCC29213 137 was also associated with a reduction in the DCS MIC from 32 to 4 g/ml. DCS is a broad- 
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NE810 exhibited a highly irregular cell shape, and many cells appeared collapsed ( Fig. 3B ). 163 TEM imaging revealed that NE810 cells had a wrinkled cell surface (Fig. 3D ), a thinner cell 164 wall (19 ± 2.5nm) compared to JE2 (26 ± 1.8nm) and increased rupturing, although cell size 165 (mean cell diameter) was unaffected (Table S2) . 166 Quantitative peptidoglycan compositional analysis was performed using UPLC analysis of 167 muramidase-digested muropeptide fragments extracted from exponential phase cultures of 168 JE2 and NE810 grown for 220 mins in TSB media (Fig. S3 ). The PG profile of the cycA mutant 169 revealed a significant accumulation of tripeptides compared to wild-type JE2 ( Fig. 4A-C) , 170 which was associated with a significant reduction in crosslinking ( Fig. 4D ). In NE810, the 171 dimer, trimer and tetramer fractions were decreased, which was accompanied by a 172 concomitant increase in the monomer fraction ( Fig. 4E ). Consistent with this data, exposure 173 of JE2 to DCS 8g/ml was also associated with a similar accumulation in muropeptides with 174 tripeptide stems ( (Table 1) . Oxacillin and nafcillin 194 were not included in checkerboard assays because measurement of their MICs involves 195 supplementing the media with 2% NaCl, which distorts the MIC of DCS (data not shown). 196 Using the MRSA strains JE2, USA300, DAR173, DAR22, DAR169 and their corresponding cycA 197 mutants, the kinetics of killing by DCS, oxacillin and cefoxitin, alone and in combination was (Table 2) . 223 This synergy appears to be specific to -lactams and no synergy (ΣFICs > 0.5) was measured 224 between DCS and several antibiotics that are used topically or systemically for the 225 decolonization or treatment of patients colonized/infected with S. aureus or MRSA 226 (clindamycin, trimethoprim, mupirocin, ciprofloxacin), or several antibiotics to which S. 227 aureus isolates commonly exhibit resistance (tobramycin, kanamycin and spectinomycin) 228 (Table S1 ). Furthermore the cycA mutation had no impact on susceptibility to any of these 229 non--lactam antibiotics (apart from clindamycin resistance which is encoded by ermB on 230 the transposon). CFUs recovered from the kidneys of mice infected with NE810 (1.5  10 8  1.49  10 8 ) was 239 higher than for mice infected with JE2 (5.7  10 7  6.3  10 7 ), but did not reach significance. 240 Interestingly, NE810 colonies exhibited visibly increased haemolytic activity on sheep blood 241 agar ( Fig. S5A ). We previously reported that increased haemolytic activity in MSSA strains 242 was associated with increased expression of the cell-density controlled, global accessory 243 gene regulator (agr) system (4, 21, 25). Comparison of agr (RNAIII) temporal expression 244 using RT-qPCR revealed a more significant activation of the agr system after 6 hrs growth in 245 NE810 compared to JE2 (Fig. S5B ). This difference in agr activation was not related to any 246 change in growth of NE810 compared to JE2 ( Fig. S5C ). Taken together these data indicate 247 that increased -lactam susceptibility in the NE810 cycA mutant is accompanied by both 248 increased agr expression and haemolytic activity, and a trend towards increased virulence in 249 this model. 250 Treatment with oxacillin or DCS alone significantly reduced the number of CFUs recovered 251 from the kidneys of mice infected with JE2 ( Fig. 6 ). Furthermore the oxacillin/DCS 252 combination was significantly more effective than either antibiotic alone and the 253 combination was equally effective in reducing the bacterial burden in the kidneys of animals 254 infected with JE2 or NE810 when compared to no treatment (p≤0.0001) ( The exploitation of antibiotic re-purposing as part of concerted efforts to address the 276 antimicrobial resistance crisis has been hampered by a lack of mechanistic data to explain 277 demonstrated therapeutic potential and the perception that studies attempting to identify 278 new uses for existing drugs are not hypothesis-driven. However, basic research discoveries 279 that advance our understanding of bacterial virulence and antibiotic resistance mechanisms 280 can also be used to inform targeted antibiotic re-purposing, in which the mechanism of 281 action is understood. In this study, we identified an alanine permease (CycA) required for infections, for which long-term therapy is required (30). Oxacillin/DCS combination therapy 304 was significantly more effective than DCS or oxacillin alone over a 5-day therapeutic window 305 suggesting that further studies on using DCS to augment -lactams as a treatment option for 306 recalcitrant staphylococcal infections is merited. 307 The alanine permease identified in this study, CycA, shares 46% and 53% identity with CycA (Table S3) entire library was screened in duplicate and putative cefoxitin susceptible mutants were 379 tested at least five times. This susceptibility of cefoxitin sensitive mutants to oxacillin was 380 also determined by E-test, as well as broth and plate dilution assays. 381 PCR was used to verify the presence of the transposon insertion NE810 using the primers 382 NE810_Fwd and NE810_Rev (Table S4 ). Phage 80 was used to transduce the transposon 383 mutation from NE810 back into JE2 and USA300 to ensure that secondary mutations were 384 not involved in increased cefoxitin susceptibility phenotype. DNA extracted from 385 transductants selected on BHI agar supplemented with erythromycin 10g/ml were verified 386 by PCR using primers NE810_Fwd and NE810_Rev. Comparative whole genome sequencing 387 of JE2 and NE810 (MicrobesNG, UK) using the USA300_FPR3757 genome as a reference 388 revealed the absence of other mutations in NE810. 389 To complement NE810, the cycA gene was amplified from JE2 on a 1608 bp PCR product 390 using primers NE810F1_Fwd and NE810F1_Rev (Table S4) (Table S4) . 412 The following cycling conditions were used: 95 o C for 5 minutes and followed by 45 cycles of BHI media and grown at 37°C to A 600 = 1. The cells were pelleted at 8,000 × g before being 432 re-suspended in fixation solution (2.5% glutaraldehyde in 0.1 M cacodylate buffer [pH 7.4]) 433 and incubated overnight at 4°C. The fixed cells were further treated with 2% osmium 434 tetroxide, followed by 0.25% uranyl acetate for contrast enhancement. The cell pellets were 435 then dehydrated in increasing concentrations of ethanol as described above for the SEM cell C Figure S6 . Combination therapy with D-cycloserine and oxacillin significantly reduces the bacterial burden in the spleen of mice infected with MRSA. The number of colony-forming units (CFU) recovered from the spleens of mice infected by tail vein injection with 5 × 10 6 JE2 or NE810 (CycA) and left untreated or treated with 75mg of oxacillin (Ox)/kg, 30mg of DCS/kg or a combination of both Ox and DCS delivered subcutaneously every 12 hours for 5 days. The first antibiotic dose was given 16 hours after infection. Significant differences determined using one-way ANOVA with Kruskal-Wallis test followed by Dunn's multiple comparisons test are denoted using asterisks (*p≤0.05). The limit of detection (50 colonies) is indicated with a hashed red line. Figure S7 . Amino acid consumption by JE2 and NE810 grown aerobically in chemically defined media lacking glucose(CDM). Residual amino acids were measured in spent media after 0, 4, 6 and 8 h growth. 
